87% of respondents deemed mRNA a key modality for the future More than 60% vaccine makers surveyed plan revamp or new facilities for...
ByE NEWSJune 1, 2023CDMO joins United Nations Global Compact Globally, Vetter is one of over 300 companies in the pharma and biotech industry that have signed...
ByE NEWSMarch 9, 2023Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development Clinical development pipeline is essential to global business...
ByE NEWSFebruary 2, 2023The pharmaceutical service provider significantly increases its sustainability rating Vetter among the top five percent in the industry Result acknowledges strong sustainability commitment...
ByE NEWSJanuary 19, 2023